Teladoc Health, Inc. (TDOC) FY2025 10-K Annual Report
Teladoc Health, Inc. (TDOC) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 26, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Teladoc Health, Inc. FY2025 10-K Analysis
Business Overview
- • Core business model: Global virtual care leader offering integrated healthcare services via technology platforms to employers, health plans, and individuals
- • New emphasis on AI-enhanced capabilities: Advanced AI-driven predictive analytics, personalized engagement, and AI-enabled clinical documentation improvements launched in Prism platform
Management Discussion & Analysis
- • Revenue details for FY2025 vs FY2024 omitted; see 2024 10-K filed Feb 27, 2025 for full YoY analysis
- • U.S. Integrated Care members +9% YoY, increased by 8.0 million to 101.8 million as of Dec 31, 2025
Risk Factors
- • Regulatory risk: Impact of Patient Protection and Affordable Care Act (PPACA) and related laws reducing Medicare payments up to 2% annually through 2030
- • Geopolitical/macroeconomic threat: Revenue risk from potential Client mergers/acquisitions causing contract cancellations or non-renewals impacting 19% total revenue from top five Clients
Teladoc Health, Inc. FY2025 Key Financial MetricsXBRL
Revenue
$2.5B
▼ -1.5% YoY
Net Income
-$200M
▲ +80.0% YoY
Operating Margin
-10.4%
▲ +2934bp YoY
Net Margin
-7.9%
▲ +3105bp YoY
ROE
-14.5%
▲ +5269bp YoY
Total Assets
$2.9B
▼ -18.7% YoY
EPS (Diluted)
$-1.14
▲ +80.6% YoY
Operating Cash Flow
$294M
▲ +0.2% YoY
Source: XBRL data from Teladoc Health, Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Teladoc Health, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.